Vext Science, Inc. (VEXT.CN)
CAD 0.13
(4.0%)
CAD 0.13
(4.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.8 Million USD | -187.63% |
| 2022 | 8.92 Million USD | -5.87% |
| 2021 | 9.48 Million USD | 194.84% |
| 2020 | 3.21 Million USD | -10.4% |
| 2019 | 3.59 Million USD | -36.21% |
| 2018 | 5.62 Million CAD | -1.59% |
| 2017 | 5.72 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -3.66 Million USD | 63.44% |
| 2024 Q1 | -3.76 Million USD | 52.55% |
| 2023 Q3 | -1.89 Million USD | -537.69% |
| 2023 Q2 | 433.53 Thousand USD | -19.41% |
| 2023 Q4 | -7.65 Million USD | -303.49% |
| 2023 Q1 | 537.94 Thousand USD | -46.82% |
| 2023 FY | -7.82 Million USD | -187.63% |
| 2022 Q2 | 2.6 Million USD | -50.62% |
| 2022 Q1 | 5.26 Million USD | 144.64% |
| 2022 FY | 8.92 Million USD | -5.87% |
| 2022 Q3 | 1.23 Million USD | -52.43% |
| 2022 Q4 | 1.01 Million USD | -18.27% |
| 2021 Q3 | 2.47 Million USD | -1.49% |
| 2021 Q2 | 2.51 Million USD | 32.01% |
| 2021 Q1 | 1.9 Million USD | 22.03% |
| 2021 FY | 9.48 Million USD | 194.84% |
| 2021 Q4 | 2.15 Million USD | -12.97% |
| 2020 FY | 3.21 Million USD | -10.4% |
| 2020 Q1 | -922.62 Thousand USD | 26.74% |
| 2020 Q4 | 1.55 Million USD | -8.28% |
| 2020 Q3 | 1.7 Million USD | 66.27% |
| 2020 Q2 | 1.02 Million USD | 210.82% |
| 2019 FY | 3.59 Million USD | -36.21% |
| 2019 Q2 | 1.52 Million USD | -30.78% |
| 2019 Q1 | 2.2 Million USD | 101.9% |
| 2019 Q4 | -1.25 Million USD | -213.8% |
| 2019 Q3 | 1.1 Million USD | -27.58% |
| 2018 Q2 | 1.31 Million USD | -7.59% |
| 2018 Q3 | 1.79 Million USD | 36.11% |
| 2018 Q4 | 1.09 Million USD | -39.02% |
| 2018 FY | 5.62 Million CAD | -1.59% |
| 2018 Q1 | 1.42 Million USD | 0.0% |
| 2017 FY | 5.72 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | -51.317% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 44.565% |
| Blueberries Medical Corp. | -1.22 Million CAD | -46.923% |
| The BC Bud Corporation | -1.22 Million CAD | -47.294% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 71.697% |
| CordovaCann Corp. | -2.51 Million CAD | 28.276% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -104.658% |
| Captor Capital Corp. | 655.2 Thousand CAD | 375.044% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -80.853% |
| 1CM Inc. | 300.79 Thousand CAD | 699.124% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -226.642% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 53.543% |
| IM Cannabis Corp. | -12.17 Million CAD | 85.198% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 46.356% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -359.469% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 43.437% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 432.327% |
| Ovation Science Inc. | -764 Thousand CAD | -135.876% |
| Pharmadrug Inc. | -1.33 Million CAD | -34.988% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -57.807% |
| RAMM Pharma Corp. | -7.08 Million CAD | 74.569% |
| RIV Capital Inc. | 1.78 Million CAD | 201.229% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 45.159% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 79.449% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 69.897% |
| 1933 Industries Inc. | -9.34 Million CAD | 80.725% |
| Red Light Holland Corp. | -6.44 Million CAD | 72.045% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -129.626% |
| Xebra Brands Ltd. | -1.55 Million CAD | -15.926% |
| Adastra Holdings Ltd. | -1.79 Million CAD | -0.466% |